Literature DB >> 8574004

An ultrastructural study of neuronal changes in dorsal root ganglia (DRG) of rats after chronic cisplatin administrations.

R Cece1, M G Petruccioli, G Cavaletti, I Barajon, G Tredici.   

Abstract

In humans, the main dose-limiting side-effect of cisplatin (CDDP) treatment is a peripheral sensory neuropathy secondary to dorsal root ganglion (DRG) neuron involvement. To investigate further for neuronal alterations responsible for CDDP neurotoxicity we undertook the present experimental ultrastructural study, based on observations of 3 different groups of rats (6 animals in each group). Group A rats were treated with 1 mg/kg weekly for 9 weeks; Group B with 2 mg/kg weekly for 9 weeks; and group C rats served as untreated controls. At the end of the experiment, rats were perfused with 3% glutaraldehyde and lumbar DRGs were prepared for electron microscopic observations. In CDDP-treated rats somatic, nuclear and, above all, nucleolar size was reduced. Ultrastructurally, the nucleolus was the most affected structure. Nucleolar alterations were quantified morphometrically. Less marked changes were seen in the nucleus and in the RER and Golgi apparatus of the cytoplasm. The number of lysosomes and lipofuscins was greatly increased in CDDP-treated rats. The ultrastructural alterations observed in CDDP rats suggest that CDDP may be neurotoxic due to a reduction in protein synthesis. This assumption would explain why cells such as neurons, which are non replicating, but which have a high rate of protein synthesis, may be the target of the neurotoxic action of CDDP. The lack of an efficient blood/nerve barrier in the DRG explains the involvement of this particular type of neuron.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574004

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  10 in total

1.  Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration.

Authors:  G Tredici; S Tredici; D Fabbrica; C Minoia; G Cavaletti
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

2.  Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy.

Authors:  Ilja Bobylev; Abhijeet R Joshi; Mohammed Barham; Wolfram F Neiss; Helmar C Lehmann
Journal:  Mol Neurobiol       Date:  2017-01-21       Impact factor: 5.590

3.  Protective effect of amifostine against cisplatin-induced motor neuropathy in rat.

Authors:  Suayib Yalcin; Gulay Nurlu; Bülent Orhan; Dilara Zeybek; Sevda Müftüoğlu; Banu Sarer; Berna Akkuş Yildirim; Eren Cetin
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

4.  Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells.

Authors:  Bart A J Jansen; Peter Wielaard; Ganna V Kalayda; Maura Ferrari; Chris Molenaar; Hans J Tanke; Jaap Brouwer; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2004-04-08       Impact factor: 3.358

Review 5.  DNA damage response in peripheral nervous system: coping with cancer therapy-induced DNA lesions.

Authors:  Ella W Englander
Journal:  DNA Repair (Amst)       Date:  2013-05-16

6.  Enolate-forming compounds provide protection from platinum neurotoxicity.

Authors:  Brian C Geohagen; Daniel A Weiser; David M Loeb; Lars U Nordstroem; Richard M LoPachin
Journal:  Chem Biol Interact       Date:  2020-01-21       Impact factor: 5.192

7.  Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle.

Authors:  J S Gill; A J Windebank
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

8.  Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats.

Authors:  Bulent Orhan; Suayib Yalcin; Gulay Nurlu; Dilara Zeybek; Sevda Muftuoglu
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

9.  Nucleolar damage correlates with neurotoxicity induced by different platinum drugs.

Authors:  M J McKeage; T Hsu; D Screnci; G Haddad; B C Baguley
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

10.  Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity.

Authors:  S M F Jamieson; J Liu; T Hsu; B C Baguley; M J McKeage
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.